Clinical Scorecard: AAP Releases 2025 Child Vaccination Schedule
At a Glance
| Category | Detail |
|---|---|
| Condition | Child Vaccination |
| Key Mechanisms | Immunization schedule updates for children and adolescents |
| Target Population | Children and adolescents, including specific recommendations for immunocompromised patients |
| Care Setting | Pediatric healthcare settings |
Key Highlights
- Change from quadrivalent to trivalent influenza vaccines
- Nirsevimab administration for RSV prevention within 1 week of birth
- Meningococcal B vaccination schedule updated to a two-dose series
- New contraindication for MMRV in HIV-infected patients
- Updates to polio catch-up vaccination guidelines
Guideline-Based Recommendations
Diagnosis
- Monitor immunization status and follow the updated schedule
Management
- Administer recommended vaccines according to the 2025 schedule
Monitoring & Follow-up
- Report adverse events to the Vaccine Adverse Event Reporting System
Risks
- Consider contraindications for specific vaccines in high-risk populations
Patient & Prescribing Data
Children and adolescents, including those with specific medical indications
Guidance for additional doses for moderately or severely immunocompromised patients
Clinical Best Practices
- Utilize the complete vaccination schedule published by AAP and CDC
- Ensure informed decision-making for vaccinations in adolescents aged 16 to 23 years
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
